针对北美土著人民的文化定制的物质使用干预措施:系统性审查
Ariel M S Richer1, Ariel L Roddy2
1School of Social Work, Columbia University, New York City, New York, USA.
概括
针对北美土著成年人的文化定制干预措施显示出解决酒精和毒品使用问题的前景. 需要更多的研究来开发可访问,有效和文化融合的治疗选择.
科学领域:
- 公共卫生 公共卫生
- 土著健康土著健康
- 药物使用障碍 药物使用障碍
背景情况:
- 对北美土著社区而言,物质使用是一个重大的健康问题.
- 原住民人口面临的过量吸毒死亡率不成比例.
- 对可获得,有效和文化相关的治疗选择的有限参与阻碍了土著个人的康复.
研究的目的:
- 系统地审查同行评审的关于北美土著成年人中酒精和毒品使用的文化定制干预措施的文献.
- 确定有效的文化整合性治疗选择的特征.
- 强调需要增加该领域的研究投资.
主要方法:
- 从2000年到2021年4月,对电子数据库 (PsycINFO,CINAHL,MEDLINE,PubMed) 的系统审查.
- 两名审稿人选了摘要,以便将其纳入研究.
- 综述中包括了18项研究.
主要成果:
- 大多数研究 (89%) 都是在美国进行的,主要是在部落/农村环境 (61%).
- 干预措施主要针对酒精和毒品的联合使用 (72%),很少有人专注于特定物质,如阿片类药物 (6%).
- 住院治疗环境是最常见的 (39%).
结论:
- 根据文化定制的干预措施对于解决土著社区中物质使用问题至关重要.
- 需要增加对不同土著人口的文化整合性治疗选择的研究投资.
- 了解干预特征可以为开发更有效和更容易获得的服务提供信息.
更多相关视频
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
8.0K
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
相关概念视频
Community Based Intervention
66
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
66
Drug Abuse and Addiction: Pharmacological Phenomena
563
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
563
Substance Use Disorders Affecting Sleep
199
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
199
Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Control Governance: Regulatory Bodies and Their Impact
196
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
196
